Nuclear Medicine News and Research

RSS

Nuclear medicine is a branch or specialty of medicine and medical imaging that uses radioactive isotopes (radionuclides) and relies on the process of radioactive decay in the diagnosis and treatment of disease. In nuclear medicine procedures, radionuclides are combined with other chemical compounds or pharmaceuticals to form radiopharmaceuticals.

GE Healthcare concentrates on healthymagination to help patients live longer and healthier

Miniaturized ultrasound. Navigation during interventional procedures. Innovations in sound wave imaging. At RSNA 2009, GE Healthcare is finding better ways to see more. And using that information to do more.

30 Nov 2009

TomTec Imaging Systems showcases its new cardiac multimodality workstation at the RSNA

TomTec, the leading innovator for cardiac image analysis and image management, shows its new cardiac multimodality workstation at the RSNA in Chicago!

25 Nov 2009

Study: On-call radiology residents accurately interpret most emergency neuroradiology CT scans

On-call radiology residents generally provide accurate preliminary interpretation of emergency neuroradiology CT scans after hours when attending neuroradiologist unavailable, according to results of a large study performed at a level I trauma center published in the December issue of the Journal of the American College of Radiology (JACR).

25 Nov 2009

Seven-day event focuses on nuclear medicine, molecular imaging, nanomedicine and clinical trials

SNM will hold its Conjoint Mid-Winter Meetings Jan. 27-Feb. 2, 2010, at the Albuquerque Convention Center in Albuquerque, N.M. This year, SNM joins its annual Mid-Winter Educational Symposium with the 2010 Annual Meeting and Educational Symposium of the American College of Nuclear Medicine (ACNM), the Nanomedicine and Molecular Imaging Summit and the Clinical Trials Network Community Workshop.

25 Nov 2009

Journal policies call for authors to disclose COIs for improved transparency

Nearly 90 percent of medical journals with relatively high impact factors have policies addressing author conflict of interest (COI) available for public review, according to a report in the November 25 issue of JAMA. But many journals do not require authors to sign disclosure statements, and there is variability in how COI is defined.

25 Nov 2009

JACR: Computerized support system provides solution to manage imaging utilization

Providing physicians with a computerized order entry/decision support system that provides immediate feedback regarding imaging appropriateness at the time of ordering may be an effective solution to managing imaging utilization, according to an article in the December issue of the Journal of the American College of Radiology.

25 Nov 2009

Study shows 95 percent of radiation oncologists use FDG-PET, MRI and 4DCT to locate cancer

A recent study shows that 95 percent of radiation oncologists use advanced imaging techniques such as positron emission tomography (FDG-PET), magnetic resonance imaging (MRI), and 4-dimensional computed tomography (4DCT) for target delineation (to locate the tumor and other areas at risk for having cancer), according to an article in the December issue of the Journal of the American College of Radiology, (JACR, www.jacr.org).

25 Nov 2009

Perceptive Informatics announces the expansion of its medical imaging capabilities for cardiology clinical trials

Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation, today announced that it has expanded its leading medical imaging capabilities with advanced nuclear imaging functionality for cardiology clinical trials.

From Parexel 17 Nov 2009

UC San Diego Medical Center to implement Allocade's On-Cue System

As part of ongoing efforts to improve patient services, the Department of Radiology at UC San Diego is participating in the Enterprise Patient Flow (EPF) Study. UC San Diego Medical Center will implement the On-Cue™ System -- developed by Allocade, Inc., a developer of innovative healthcare software solutions -- to study process improvement, resource utilization, communication and patient experience.

17 Nov 2009

Changes in CMS reimbursement to accelerate demand for cardiac PET imaging

Positron Corporation a molecular imaging solutions company focused on Nuclear Cardiology, expects the evolution from cardiac SPECT to cardiac PET imaging will be greatly accelerated with the recent changes in reimbursement from the Centers for Medicare & Medicaid Services (CMS) set for 2010.

13 Nov 2009

CMS approves FDG PET for initial staging of cervical cancer

SNM applauds the Centers for Medicare & Medicaid Services- (CMS) decision to expand coverage of FDG PET for the initial staging of cervical cancer without previously imposed restrictions.

13 Nov 2009

UOHI to receive $5.4M federal funds for development of new alternative radioisotope imaging tracers

Researchers from the University of Ottawa Heart Institute (UOHI) will receive nearly half of a $5.4 million federal fund to help solve a shortage of medical isotopes resulting from the shutdown of the Chalk River nuclear reactor. Two research teams will develop two new alternative radioisotope imaging tracers, test new applications for their use in diagnosing heart disease, and fast track production and distribution as quickly as possible across Canada.

10 Nov 2009

SNM commends the U.S. House of Representatives for its passage of medical isotope legislation

SNM applauds the U.S. House of Representatives for its passage of H.R. 3276-the American Medical Isotopes Production Act of 2009.

7 Nov 2009

Successful leukemia treatment with a radiolabeled antibody followed by stem cell transplant

For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a group of leukemia and pre-leukemia patients for whom there previously had been no other curative treatment options.

6 Nov 2009

Molecular imaging pinpoints inflammation in the brains of schizophrenics and migraine sufferers

Inflammatory response of brain cells-as indicated by a molecular imaging technique-could tell researchers more about why certain neurologic disorders, such as migraine headaches and psychosis in schizophrenic patients, occur and provide insight into how to best treat them, according to two studies published in the November issue of the Journal of Nuclear Medicine.

31 Oct 2009

Bayer HealthCare's Phase II study results of imaging agent florbetaben

Bayer HealthCare presented results from a global Phase II study of florbetaben, its imaging agent in development for the detection of cerebral beta-Amyloid plaques, at the 19th World Congress of Neurology (WCN).

30 Oct 2009

Researchers report preclinical results of a novel PET biomarker designed to detect malignant breast tumors

Researchers at Thomas Jefferson University in Philadelphia, PA, supported in part by NuView Life Sciences, have published an article in the Journal of Nuclear Medicine reporting preclinical results of a novel PET biomarker designed to selectively detect malignant breast tumors.

30 Oct 2009

Residents can serve a vital role in promoting CT colonography awareness

Residents can serve a vital role in educating Congress, the medical community, and the general public regarding the efficacy of cutting-edge technologies like CT colonography (CTC) as well as the importance of radiologists' training and education and the role that radiologists serve in the provision of quality health care, according to an article published in the November issue of the Journal of the American College of Radiology (JACR).

29 Oct 2009

Inpatient diagnostic imaging exams achieve lower in-hospital mortality rates, shows study

Hospitals that make greater use of inpatient diagnostic imaging exams achieve lower in-hospital mortality rates with little or no impact on costs, according to a peer-reviewed study of more than 1 million patient outcomes in more than 100 hospitals nationwide published in the November issue of the Journal of the American College of Radiology (JACR).

29 Oct 2009

Pulmo BioTech signs agreement with Biotechnology Consulting Poland for commercialization of PulmoBind

Pulmo BioTech Inc. has announced that it will ultimately receive at least $3.3 million pursuant to the license agreement contemplated by the previously announced non-binding letter of intent with Biotechnology Consulting Poland Sp. z.o.o. with respect to its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM) development work, clinical trials and ultimately, commercialization in the European market.

24 Oct 2009

Nuclear Medicine News and Research

Further Reading

GE Healthcare concentrates on healthymagination to help patients live longer and healthier

TomTec Imaging Systems showcases its new cardiac multimodality workstation at the RSNA

Study: On-call radiology residents accurately interpret most emergency neuroradiology CT scans

Seven-day event focuses on nuclear medicine, molecular imaging, nanomedicine and clinical trials

Journal policies call for authors to disclose COIs for improved transparency

JACR: Computerized support system provides solution to manage imaging utilization

Study shows 95 percent of radiation oncologists use FDG-PET, MRI and 4DCT to locate cancer

Perceptive Informatics announces the expansion of its medical imaging capabilities for cardiology clinical trials

UC San Diego Medical Center to implement Allocade's On-Cue System

Changes in CMS reimbursement to accelerate demand for cardiac PET imaging

CMS approves FDG PET for initial staging of cervical cancer

UOHI to receive $5.4M federal funds for development of new alternative radioisotope imaging tracers

SNM commends the U.S. House of Representatives for its passage of medical isotope legislation

Successful leukemia treatment with a radiolabeled antibody followed by stem cell transplant

Molecular imaging pinpoints inflammation in the brains of schizophrenics and migraine sufferers

Bayer HealthCare's Phase II study results of imaging agent florbetaben

Researchers report preclinical results of a novel PET biomarker designed to detect malignant breast tumors

Residents can serve a vital role in promoting CT colonography awareness

Inpatient diagnostic imaging exams achieve lower in-hospital mortality rates, shows study

Pulmo BioTech signs agreement with Biotechnology Consulting Poland for commercialization of PulmoBind

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News